Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001209191-21-041747

Options or other derivatives

  • Director acquired 16,625 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Svennilson Peter Director 2021-06-16 Grant or award · Stock Option (right to buy) +16,625 16,625 D
Loading xslF345X03/doc4.xml…